Manulife (Manufacturers Life Insurance)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
59,350
+3,540
| +6% | +$10.9K | ﹤0.01% | 2590 |
|
|
2025
Q1 | $195K | Buy |
55,810
+315
| +0.6% | +$1.1K | ﹤0.01% | 2507 |
|
|
2024
Q4 | $181K | Sell |
55,495
-57
| -0.1% | -$186 | ﹤0.01% | 2662 |
|
|
2024
Q3 | $214K | Sell |
55,552
-1,771
| -3% | -$6.82K | ﹤0.01% | 2637 |
|
|
2024
Q2 | $177K | Buy |
57,323
+4,191
| +8% | +$13K | ﹤0.01% | 2650 |
|
|
2024
Q1 | $137K | Buy |
53,132
+965
| +2% | +$2.49K | ﹤0.01% | 2707 |
|
|
2023
Q4 | $130K | Hold |
52,167
| – | – | ﹤0.01% | 2746 |
|
|
2023
Q3 | $106K | Hold |
52,167
| – | – | ﹤0.01% | 2787 |
|
|
2023
Q2 | $120K | Buy |
52,167
+10,006
| +24% | +$23K | ﹤0.01% | 2779 |
|
|
2023
Q1 | $128K | Hold |
42,161
| – | – | ﹤0.01% | 2690 |
|
|
2022
Q4 | $98.2K | Buy |
42,161
+168
| +0.4% | +$391 | ﹤0.01% | 2802 |
|
|
2022
Q3 | $80.2K | Sell |
41,993
-1,720
| -4% | -$3.29K | ﹤0.01% | 2860 |
|
|
2022
Q2 | $118K | Buy |
43,713
+7,629
| +21% | +$20.7K | ﹤0.01% | 2852 |
|
|
2022
Q1 | $108K | Sell |
36,084
-6,901
| -16% | -$20.6K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $167 | Sell |
42,985
-3,219
| -7% | -$13 | ﹤0.01% | 2957 |
|
|
2021
Q3 | $198K | Sell |
46,204
-2,661
| -5% | -$11.4K | ﹤0.01% | 2990 |
|
|
2021
Q2 | $148K | Buy |
+48,865
| New | +$148K | ﹤0.01% | 3192 |
|
|
2019
Q2 | – | Sell |
-26,188
| Closed | -$93K | – | 2901 |
|
|
2019
Q1 | $93K | Buy |
26,188
+15,296
| +140% | +$54.3K | ﹤0.01% | 2584 |
|
|
2018
Q4 | $42K | Sell |
10,892
-12,614
| -54% | -$48.6K | ﹤0.01% | 2490 |
|
|
2018
Q3 | $223K | Sell |
23,506
-6,390
| -21% | -$60.6K | ﹤0.01% | 2703 |
|
|
2018
Q2 | $218K | Buy |
+29,896
| New | +$218K | ﹤0.01% | 3057 |
|